Showing all 4 results
Down Risk 1st Trimester Screening offers unparalleled value by combining accuracy, safety, and early insight into your baby’s development. It empowers parents with critical information at a pivotal time, fostering confidence and informed decision-making throughout the pregnancy.
| Down’s Risk : 1st Trimester |
| Parameters |
| Free B-Hcg |
| PAPP-A |
| 11 TO 13 Weeks + 6 days |
Sample Type : Serum
Methodology : Enzyme-immunoassay
TAT : 65 Days
The Triple Test: Comprehensive Screening for Maternal and Fetal Health is a non-invasive prenatal blood test that evaluates three key biomarkers—AFP, hCG, and estriol—to assess the risk of fetal chromosomal abnormalities such as Down syndrome and neural tube defects.
Sample Type : Serum
Methodology : Enzyme-immunoassay
TAT : 3 Days
The Ultrasound NT (Nuchal Translucency) Scan is a specialized prenatal screening test performed between 11 and 14 weeks of pregnancy to assess the risk of chromosomal abnormalities such as Down syndrome. It measures the fluid at the back of the baby’s neck using high-resolution ultrasound technology. Key features include non-invasive imaging, early detection of potential genetic conditions, and precise fetal development assessment.